2015 ACR/ARHP Annual Meeting Archives

Abstract Number: 1854

Identification and Characterization of microRNAs Related to the Pathogenesis of Cardiovascular Disease in Patients with Antiphospholipid Syndrome and Systemic Lupus Erythematosus. Role of Specific Autoantibodies
Abstract Number: 2401

Identification and Characterization of Two Osteoarthritis Phenotypes Applying Two Clinically Tested Biomarkers
Abstract Number: 1885

Identification and Clinical Correlations of Rare Autoantibodies in Systemic Sclerosis and Poly/Dermatomyositis Patients
Abstract Number: 138

Identification and Documentation of Secondary Osteoarthritis in Patients with Primary Inflammatory Arthritides Using a Patient MDHAQ/RAPID3 and a Physician Estimate of Joint Damage to Recognize Patient Complexity and Inform Management Decisions
Abstract Number: 1241

Identification and Validation of Diagnostic and Activity Urinary Metabolomic Biomarkers in Immune-Mediated Inflammatory Diseases
Abstract Number: 1253

Identification and Validation of Novel Putative Salivary Proteomic Biomarkers in Sjögren’s Syndrome and Different Disease Subsets
Abstract Number: 697

Identification Methods for Axial Spondyloarthritis in American Veterans
Abstract Number: 1930

Identification of a Broadly Immunogenic Prevotella Copri T Cell Epitope in Patients with Rheumatoid Arthritis
Abstract Number: 2992

Identification of a New Set of Activity Criteria for Systemic Sclerosis. Preliminary Report
Abstract Number: 2212

Identification of a Novel Chemokine-Dependent Molecular Mechanism Underlying Rheumatoid Arthritis-Associated Autoantibody-Mediated Bone Destruction
Abstract Number: 1258

Identification of a Spectrum of Therapeutic Targets of a New Treatment for Osteoarthritis Composed By Curcuminoids Extract, Hydrolyzed Collagen and Green Tea Extract
Abstract Number: 1750

Identification of Autoantibody-Inducing CD4 T Cell (aiCD4 T cell) That Causes Systemic Lupus Erythematosus (SLE) As DOCK8+ CD4 T Cell: Proof of Concept of Self-Organized Criticality Theory
Abstract Number: 775

Identification of Candidate Items for Revised Classification Criteria for Systemic Lupus Erythematosus
Abstract Number: 1095

Identification of Carbamylated Alpha-1-Anti-Trypsin (A1AT) As an Antigenic Target of Anti-Carp Antibodies in Patients with Rheumatoid Arthritis
Abstract Number: 802

Identification of Cyclin-Dependent Kinase 1 As a Novel Regulator for Controlling Type I Interferon Signaling in Systemic Lupus Erythematosus
Abstract Number: 15L

Identification of Four-and-a-Half-LIM Domain 1 (FHL1) As a New Autoantibody Target in Idiopathic Inflammatory Myopathies
Abstract Number: 1616

Identification of Genes Regulating TRAIL-Induced Apoptosis in Rheumatoid Arthritis Fibroblasts-like Synoviocytes (RA FLS)
Abstract Number: 1953

Identification of Genetic Factors Associated with Clinical Manifestations of Giant Cell Arteritis through a Stratified Large-Scale Analysis
Abstract Number: 2094

Identification of Gout Flare Using an Administrative Claims Based Algorithm
Abstract Number: 1862

Identification of Homogeneous Systemic Lupus Erythematosus (SLE) Patient Groups Using Clustered Autoantibody Reactivities
Abstract Number: 2278

Identification of Long-Term Physical Activity Trajectories in Individuals with Chronic Widespread Pain Who Received Exercise Treatment As Part of a Randomized Controlled Trial
Abstract Number: 788

Identification of Molecular Biomarkers to Distinguish Systemic Lupus Erythematosus with Skin Involvement from Discoid Lupus Erythematosus and Subacute Cutaneous Erythematosus: Provisional Results from Cross-Sectional Studies
Abstract Number: 1134

Identification of Novel Micro-RNAs in IL-1β-Stimulated OA Chondrocytes By Next-Generation Sequencing
Abstract Number: 3227

Identification of Novel Protein-Coding Genetic Variants Associated with Takayasu Arteritis
Abstract Number: 1052

Identification of Novel Sjogren’s Syndrome Risk Loci in the Regions of TNFAIP3 and PRDM1
Abstract Number: 2797

Identification of Serum Biomarker for the Glandular Dysfunction of Primary Sjögren’s Syndrome
Abstract Number: 1022

Identification of Shared Genomic Regions in Distantly Related Pairs of Cases with Juvenile Idiopathic Arthritis
Abstract Number: 844

Identification of Subclinical Skin Involvement By High Frequency Ultrasound in Systemic Sclerosis Patients
Abstract Number: 2136

Identification of Synovial Fibroblast Subsets That Define Pathology in Rheumatoid Arthritis
Abstract Number: 2461

Identification of Target Antigens for Anti-Endothelial Cell Antibodies in Patients with Pediatric Rheumatic Diseases Using Proteomics
Abstract Number: 1243

Identification of the Gene Expression Signatures Predicting the Responses to Three Biologics (infliximab, tocilizumab, and abatacept) in Rheumatoid Arthritis
Abstract Number: 1857

Identification of the Long Noncoding RNA NEAT1 As a Novel Inflammatory Regulator Acting through MAPK Pathway in Human Lupus
Abstract Number: 2628

Identifying Anxiety and Depression Among Rheumatoid Arthritis Patients Using the Multidimensional Health Assessment Questionnaire
Abstract Number: 140

Identifying Psoriatic Arthritis and Ankylosing Spondylitis Patients Responsible for the Highest Costs of Care: Data from a Large US Cohort
Abstract Number: 1583

Identifying Risk Factors for Progression of Rheumatoid Arthritis-Associated Interstitial Lung Disease
Abstract Number: 118

Identifying the Investment Needed to Generate a Durable Prednisone Dose Decrement
Abstract Number: 1846

IGFBP-2 As a Novel Biomarker for Disease Activity and Renal Pathology in Lupus Nephritis
Abstract Number: 1799

IgG Levels Correlate Inversely with Proteinuria Among Participants in the Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis Trial, but Hypogammaglobulinemia Was Not Associated with an Increased Risk of Serious Infection
Abstract Number: 742

IgM Antibodies Against Malondialdehyde and Phosphorylcholine Are T Cell Dependent and Strong Protection Markers for Atherosclerosis in SLE
Abstract Number: 936

IL-1 Receptor Antagonist Maintains Intestinal Microbial Homeostasis to Prevent Overt Toll-like Receptor 4-Dependent Intestinal Th17 Differentiation and Autoimmune Arthritis
Abstract Number: 1136

IL-1β-Induced Stress Granules Sequester COX-2 mRNA and Regulates Its Expression in Human OA Chondrocytes
Abstract Number: 2814

IL-10 May Mitigate Cardiovascular Risk in Psoriatic Arthritis Via an Anti-Atherosclerotic Effect on Cellular Cholesterol Transport
Abstract Number: 3043

IL-17 Expression By Lymphocytes Is Higher in Behcet’s Disease Compared to Takayasu Arteritis
Abstract Number: 2813

IL-17 Induces Skin Inflammation Independently of IL-23R+ T Cells and Is Protected By Conditional Deletion of Wdfy3 in Neutrophils
Abstract Number: 1932

IL-17A-Low CCR6+ Th Cell Populations of Patients with Rheumatoid Arthritis Are Pathogenic, Multidrug Resistant and Associated with DMARD and Glucocorticoid Treatment Response
Abstract Number: 3020

IL-21 Abrogates CD4+CD25+FOXP3+ Treg Differentiation in Part By Suppressing Treg GATA-3 Expression in SLE
Abstract Number: 1377

IL-22 Drives the Proliferation and Differentiation of Human Bone Marrow Mesenchymal Stem Cells (MSCs); A Novel Pathway That May Contribute to Aberrant New Bone Formation in Human Spa and Beyond
Abstract Number: 544

IL-6 May Have an Important Role in the Resistance to Anti-TNF Therapies of Human T-Lymphotropic Virus Type 1 (HTLV-1) Positive Rheumatoid Arthritis (RA) Patients; HTLV-1 Infected Cells Activate the Inflammatory Responses of RA Synovial Fibroblasts
Abstract Number: 2761

IL-6R Blockade with Sarilumab Plus Methotrexate Results in Changes in Clinical and Laboratory Parameters Associated with Chronic Inflammation in Patients with Moderate-to-Severe RA in a Phase 3 Study
Abstract Number: 3201

IL-7 Drives Cytokine Secretion of IL-7Rabright CCR9-Expressing T-Follicular Helper-like Cells: Potential New Axis in Lymphoid Neogenesis in Salivary Glands of Primary Sjogren s Syndrome Patients
Abstract Number: 3156

IL17 Promotes Development of Autoreactive Early Stage B Cells in Distinct Regions of the Spleen Follicle
Abstract Number: 2793

IL35 Serum Level Is Decreased in Patients with Primary Sjogren Syndrome, Essentially in Patients with the More Active Disease Data from the French Prospective Assess Cohort
Abstract Number: 1162

IL37 Reduces Pro-Inflammatory Cytokine and Catabolic Enzyme Production in Human Chondrocytes: A Protective Role in Osteoarthritis?
Abstract Number: 1092

Illicit Drug Use in US Adults with Chronic Low Back Pain: Nhanes 2009-2010
Abstract Number: 1552

Illness Perceptions in Rheumatoid Arthritis: A Comparison of Canadian and Nigerian Patients
Abstract Number: 1735

Imaging and Clinical Factors Associated with Subchondral Sacroiliac Fatty Marrow in Axial Spondyloarthritis
Abstract Number: 2110

Imaging and Safety Assessments Following Treatment with Febuxostat and Placebo for 2 Years in Subjects with Early Gout
Abstract Number: 1993

Imaging Findings of Cerebral Amyloid Angiopathy, Abeta-Related Angiitis (ABRA) and Cerebral Amyloid Angiopathy-Related Inflammation: A Single Institution 25 Year Experience
Abstract Number: 1341

Imaging Growing Joints By Diffraction Enhanced-Computed Tomography Using a Synchrotron Light Source
Abstract Number: 2088

Immature Dendritic Are Potent OC Precursors in RA and Are Targeted By RA-Specific Antibodies
Abstract Number: 2709

Immediate Release of Peripheral Neutrophil Myeloperoxidase and Elastase and Formation of Extracellular Traps to Cigarette Smoking in Rheumatoid Arthritis
Abstract Number: 83

Immediate Benefits of a Multidisciplinary Educational Program for Fibromyalgia on Patients’ Pain Related Self-Efficacy and Health Locus of Control
Abstract Number: 2096

Immune Dysregulation in Patients with TRNT1 Deficiency
Abstract Number: 2563

Immune Regulation By Migrating Mesenchymal Stem Cells Ameliorate Inflammatory Arthritis in Mice
Abstract Number: 1403

Immune Related Adverse Events Associated with Immune Checkpoint Inhibitors in Cancer Patients: A Systematic Review of Case Reports
Abstract Number: 2000

Immune Response Against Â Î²2GPI Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome
Abstract Number: 531

Immune Responses to Mycobacterium Heat Shock Protein 70 Accompany Self-Reactivity to Human Bip in Rheumatoid Arthritis
Abstract Number: 3259

Immunoablation Followed By Autologous Stem Cell Transplantation in Systemic Sclerosis Patients Decreases Significantly the Interferon Signatrue
Abstract Number: 3114

Immunogenicity of Subcutaneous and Intravenous Tocilizumab As Monotherapy or in Combination with Dmards
Abstract Number: 529

Immunoglobulin-a and Immunoglobulin-G Isotypes of Anti-CCP Antibodies Are Present in the Sputum of Subjects at Risk for Future Development of RA
Abstract Number: 516

Immunological and Ultrasound Characteristics of Patients with Rheumatoid Arthritis in Clinical Remission – Can We Use These to Predict Outcomes?
Abstract Number: 2210

Immunological Dysregulation and Inadequate Hypoxia Adaptation – HIF-Stabilization As Possible Prevention of Fracture Healing Disorders in RA or Immune-Suppressed Patients
Abstract Number: 2430

Immunological Risk Factors after Rituximab Therapy in Patients with Pediatric Rheumatic Diseases – a Prospective Single-Center Study
Abstract Number: 1034

Immunomodulation By a Second-Generation Peptidyl Arginine Deiminase Inhibitor Abrogates Collagen-Induced Arthritis in a Therapeutic Protocol
Abstract Number: 530

Immunomodulation of Naïve RA Patients PBMCs with a Multi-Epitope Peptide Derived from Citrullinated Autoantigens
Abstract Number: 3193

Immunomodulatory and Antiviral Therapies in a Mouse Model of Chikungunya Viral Arthritis
Abstract Number: 2702

Immunophenotyping of Rheumatoid Arthritis Reveals the Linkage Between HLA-DRB1 Genotype, CXCR4 Expressions on Memory CD4+ T Cells, and Disease Activity
Abstract Number: 1879

Immunosuppressive “Routine”� Treatment of SSc Patients with Limited Cutaneous Involvement and Interstitial Lung Disease
Abstract Number: 2612

Impact of a Multibiomarker Disease Activity Score in Patients with Rheumatoid Arthritis Treated in a Real World Setting
Abstract Number: 1011

Impact of a Musculoskeletal “Mini-Residency” Continuing Professional Education Program on Knee MRI Orders By Primary Care Providers
Abstract Number: 2339

Impact of Abbvie’s Patient Support Program on Resource Costs in Crohn’s Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis
Abstract Number: 54

Impact of Age at Disease Diagnosis on Clinical Manifestations, Disease Activity, and Outcomes in Patients with Systemic Lupus Erythematosus: Single-Center Prospective Cohort Study
Abstract Number: 560

Impact of Anti-Citrullinated Protein Antibody Status and Response to Abatacept
Abstract Number: 471

Impact of Baseline Anti-Cyclic Citrullinated Peptide 2 Antibody Titer on Efficacy Outcomes Following Treatment with Subcutaneous Abatacept or Adalimumab
Abstract Number: 760

Impact of Baseline Concomitant Medication Use on Belimumab Efficacy and Safety in Patients with Systemic Lupus Erythematosus (SLE)
Abstract Number: 1892

Impact of Cardiac Magnetic Resonance Imaging with T1 Mapping and Multi-b Value Diffusion-Weighted Sequences in Systemic Sclerosis for the Assessment of Myocardial Microscopic Fibrosis and Perfusion
Abstract Number: 2343

Impact of Colchicine Use on the Development of Incident Coronary Artery Disease
Abstract Number: 478

Impact of Comorbidities on the Multi-Biomarker Disease Activity Test in Rheumatoid Arthritis Patients
Abstract Number: 370

Impact of Didactic Lecture on Osteoporosis Screening and Fracture Risk Assessment Among House Staff
Abstract Number: 681

Impact of Disease Duration on Patient Reported and Clinical Outcomes in Patients with Ankylosing Spondylitis Treated with Anti-TNF: An Analysis from a Prospective, Observational Registry
Abstract Number: 3158

Impact of Family History of Systemic Lupus Erythematosus on Risk of Autoimmune Diseases: National Cohort Study in Denmark 1977-2012
Abstract Number: 227

Impact of Gout on the Risk of Atrial Fibrillation
Abstract Number: 2500

Impact of Health Portal Enrollment and Electronic Appointment Reminders to Improve Appointment Attendance at an Academic Rheumatology Clinic
Abstract Number: 425

Impact of in Utero Hydroxychloroquine Exposure on Age of Onset of Cutaneous Neonatal Lupus
Abstract Number: 3252

Impact of Knee Pain Frequency on Physical Function in the Osteoarthritis Initiative
Abstract Number: 1500

Impact of Menopause on Functional Impairment of Rheumatoid Arthritis Patients
Abstract Number: 2869

Impact of Methotrexate on the Real-World Effectiveness of Golimumab in Psoriatic Arthritis
Abstract Number: 38

Impact of Obesity on the Disease Course of Rheumatoid Arthritis
Abstract Number: 791

Impact of Online Education and Social Media Intervetion for Self-Management in Adolescents with SLE
Abstract Number: 1589

Impact of Osteoarthritis of the Hand on Disease Activity Scores and Health Status in Patients with Rheumatoid Arthritis
Abstract Number: 1287

Impact of Participation in Adalimumab Patient Support Program (PSP) on Clinical Outcomes and Predictors of PSP Utilization Among Patients with Rheumatoid Arthritis
Abstract Number: 2650

Impact of Patient Education on the Satisfaction of Rheumatoid Arthritis Patient : A Randomized Trial of Nurse-Led Vs. Physician-Led Education
Abstract Number: 3136

Impact of Prokinetic Agents on Systemic Sclerosis-Associated Gastrointestinal Disease: A Systematic Review
Abstract Number: 2488

Impact of Protocolized Tight Control and Biological Dose Optimization in Daily Clinical Practice: Results of a Pilot Implementation Study
Abstract Number: 508

Impact of Race on Patient Global Scores and the Misclassification of Disease Activity
Abstract Number: 1329

Impact of Repeating Imaging of the Sacroiliac Joints after One Year on the Classification of Patients According the ASAS Axial Spa Criteria
Abstract Number: 435

Impact of Sarilumab on Fatigue, Pain, Morning Stiffness, Productivity, and Health Related Quality of Life (HRQoL) in Patients with Active Rheumatoid Arthritis Who Were Inadequate Responders or Intolerant of Anti-TNF-Î± Therapy: Results from a Phase 3 Study (RCT)
Abstract Number: 2173

Impact of Smoking on Patient-Reported Disease Status and Symptoms Among Women with Lupus
Abstract Number: 1874

Impact of Socioeconomic Status on Survival in Connective Tissue Disease Associated and Idiopathic Pulmonary Arterial Hypertension
Abstract Number: 2867

Impact of Timely Versus Delayed Use of Anti-Tumor Necrosis Factor (TNF) Biologics in the Treatment of Psoriatic Arthritis: Results from a Modeling Study
Abstract Number: 2771

Impact of Tocilizumab Monotherapy in Patients with Moderate to High Disease Activity: Real-World Analyses from the US Corrona Registry
Abstract Number: 2756

Impact of Tocilizumab Monotherapy on Patient-Reported Quality of Life Outcomes in the US Corrona Registry
Abstract Number: 2279

Impacts on Work: Arthritis Vs Chronic Joint Symptoms without Arthritis
Abstract Number: 1595

Impaired Coronary Flow Reserve in Rheumatoid Arthritis: A Robust Indicator of Cardiac Structure Associated with Systemic Inflammation and Rheumatoid Arthritis Treatments
Abstract Number: 606

Impaired Kidney Function Improves Treatment Response after 6 Months of Methotrexat Treatment in Rheumatoid Arthritis Patients
Abstract Number: 3214

Impaired Phagocytosis of Apoptotic Cells in Pristane-Induced Lupus Simulates the Clearance Defect in Human SLE
Abstract Number: 838

Impaired Quality of Life in Systemic Sclerosis and Patient Perception of the Disease: A Large International Survey
Abstract Number: 1037

Impaired Regulatory T Cell Survival in the Pathogenesis of Autoreactive Arthritis Mediated By CD11c-Deletion of Flip
Abstract Number: 1492

Implementation in Clinical Practice of a Medication Assessment Tool Specific for Rheumatoid Arthritis, Rhmat
Abstract Number: 125

Implementation of a Bone Health Team Markedly Improves Osteoporosis Screening, Diagnosis and Treatment Initiation Rates Compared to Standard Primary Care Practice
Abstract Number: 2490

Implementation of Disease Activity Measurement for Rheumatoid Arthritis Patients in an Academic Rheumatology Clinic
Abstract Number: 2502

Implementation of New Pneumococcal Vaccination Recommendations in an Academic Rheumatology Clinic
Abstract Number: 2492

Implementation of the Clinical Disease Activity Index to Treat to Target Rheumatoid Arthritis in the Ambulatory Setting: A Plan Do Study Act Quality Analysis
Abstract Number: 1547

Implementing an Electronic Medical Recorded-Based Clinical Decision Support Tool Did Not Improve Cardiovascular Risk Screening in Rheumatoid Arthritis Patients
Abstract Number: 2404

Implications of a Positive Patellar Bulge Sign of Knee Joint Effusion in Patients with Osteoarthritis: Association with MRI Signs of Inflammation and with Increased Rate of 5-Year Total Knee Arthroplasty. Data from the Osteoarthritis Initiative
Abstract Number: 2583

Important Role of CD11c+ Dendritic Cells in Inflammatory Arthritis
Abstract Number: 1036

Important Role of microRNA-146a in Inflammatory Arthritis By Controlling Local Bone Destruction
Abstract Number: 2665

Improved Flare/ Remission Pattern in Rheumatoid Arthritis over the Recent Decades
Abstract Number: 141

Improved Follow-up of Hypertension in Rheumatology Patients: Results of a Pilot
Abstract Number: 2503

Improved Pneumococcal Vaccination in Rheumatoid Arthritis Patients in an Urban Academic Rheumatology Clinic
Abstract Number: 1084

Improved Survival in Granulomatosis with Polyangiitis: A General Population-Based Study
Abstract Number: 877

Improved Survival in Granulomatosis with Polyangiitis: A Population-Based Study
Abstract Number: 3240

Improved Survival in Rheumatoid Arthritis: A General Population-Based Study
Abstract Number: 985

Improved Survival in Systemic Lupus Erythematosus: A Population-Based Study
Abstract Number: 1768

Improved Tissue Clearing and 2-Photon Imaging of Mouse Kidneys Reveals Immune Cell Architecture in Nephrotoxic Nephritis
Abstract Number: 561

Improvement in Disease Activity and the Long-Term Risk of Serious Infectious Events in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol
Abstract Number: 2292

Improvement in Function and Pain Due to Subacromial Bursitis As Related to Dose of Triamcinolone Acetonide or Methylprednisolone Acetate
Abstract Number: 1014

Improvement in Mentoring Associated with Implementation of an Inter-Institutional Mentoring Program within Pediatric Rheumatology
Abstract Number: 1999

Improvement in Mortality in RA Compared to the General Population – Closing the Mortality Gap
Abstract Number: 2340

Improvement in Treat to Target Serum Urate Levels: Preliminary Results from a Comparison Between Two Audits of Management
Abstract Number: 1276

Improvement in Work and Household Productivity for Patients with Rheumatoid Arthritis and Ankylosing Spondylitis Treated with Anti-TNFs in Routine Clinical Practice in Turkey
Abstract Number: 2493

Improvement of Disease Activity and Quality of Care in a Cohort of Rheumatoid Arthritis Patients Treated with Conventional Dmard Therapy Under Treat to Target Recommendations and a Model of Patient-Centered Care
Abstract Number: 1476

Improvement of the Long-Term Outcome in Greek Adult Patients with Juvenile Idiopathic Arthritis in the 21st Century
Abstract Number: 1786

Improvements in Health-Related Quality of Life and Fatigue Following Administration of an IL-6 Monoclonal Antibody (PF-04236921) in an Enriched Population of Subjects with Active SLE
Abstract Number: 2541

Improving Adherence with Treat to Target in Rheumatoid Arthritis through a Learning Collaborative: Rationale and Design of the Traction Trial
Abstract Number: 699

Improving Ankylosing Spondylitis Specific Outcomes at 6 Months Utilising a Novel Self-Management Education Program
Abstract Number: 2223

Improving Clinical Decisions for Rheumatoid Arthritis Management Using Online Medical Simulations
Abstract Number: 1029

Improving Gout Outcomes Using a Disease Management Program within an Integrated Health System
Abstract Number: 2219

Improving Outcomes with a Multimedia Patient Education Tool in Patients with Osteoporosis after 6 Months. a Randomized Controlled Trial
Abstract Number: 1028

Improving Pneumococcal Immunization Rates Among Immunocompromised Adolescent Patients at a Tertiary Care Children’s Hospital
Abstract Number: 1297

Improving the Medication Prior Authorization Process in a University Based Rheumatology Practice
Abstract Number: 950

In a Two-Year Double-Blind Randomized Controlled Multicenter Study, Chondroitin Sulfate Was Significantly Superior to Celecoxib at Reducing Cartilage Loss with Similar Efficacy at Reducing Disease Symptoms in Knee Osteoarthritis Patients
Abstract Number: 509

In Early Undifferentiated Polyarthritis, 14-3-3η Seroreversion or Sustained Negativity Is Associated with Better Radiographic Outcomes, Even in DAS-28 Remitters
Abstract Number: 519

In Indigenous North Americans at High Risk for RA Complement C5 Level Is Associated with ACPA Positivity and C5a with Transition to Synovitis Even after Correcting for in Vitro Complement Activation Found with Prolonged Sample Storage
Abstract Number: 3199

In Rheumatoid Arthritis (RA) Patients, Retreatment with Rituximab (RTX) at Half Dose Does Not Alter Maintenance on Drug and Allows One Third Reduction of Cumulative Dose of Drug/Year: Data from the Autoimmunity and Rituximab (AIR) Registry
Abstract Number: 995

In Rheumatoid Arthritis Only a Few Expanded T-Cell Clones Dominate in Joint Inflammation: A Study in Seven RA Patients Undergoing Paired Synovial Tissue Biopsies in Multiple Joints
Abstract Number: 966

In Rheumatoid Arthritis, Smoking Is Not Associated with Anti-Citrullinated Protein Antibodies per Se, but with the Concurrent Presence of Rheumatoid Factor, Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies
Abstract Number: 3110

In the Multicenter Randomized Controlled Rotation or Change Trial, a Non-TNF Targeted Therapy Has a Higher Efficacy Than a Second Anti-TNF at 3, 6 and 12 Months
Abstract Number: 2199

in Vivo Ubiquinol Supplementation Reduces the Pro-Atherothrombotic Status in Antiphospholipid Syndrome Patients. Preliminary Results of a Clinical Trial
Abstract Number: 1984

Incidence and Intensity of 18fdg Uptake on Whole Body PET/CT in Patients with Polymyalgia Rheumatica
Abstract Number: 1472

Incidence and Mortality in a Population-Based Cohort of Patients with Juvenile Arthritis 1960-2013
Abstract Number: 792

Incidence and Persistence of Cervical Human Papillomavirus Infection in Mexican Systemic Lupus Erythematosus Women
Abstract Number: 850

Incidence and Predictors of Severe Heart Disease in Systemic Sclerosis
Abstract Number: 1970

Incidence and Predictors of Thoracic Aortic Damage in Biopsy-Proven Giant Cell Arteritis: A Single-Institution Cohort Study
Abstract Number: 2123

Incidence and Prognosis of Neonatal and Late-Onset Dilated Cardiomyopathy Associated with Cardiac Neonatal Lupus
Abstract Number: 1514

Incidence and Risk Factors of Malignancy in a Cohort of Rheumatoid Arthritis Patients from Singapore
Abstract Number: 3112

Incidence of Anti-Drug Antibodies in Rheumatoid Arthritis Patients Treated with Adalimumab, Etanercept, or Infliximab in a Real-World Setting
Abstract Number: 1512

Incidence of Co-Morbid Autoimmune Diseases in Patients with Rheumatoid Arthritis
Abstract Number: 369

Incidence of Fragility Hip Fractures over 10 Years (2004-13) in Three UK Centres with Reference to Local Fracture Prevention (‘fracture liaison’) Service Activity
Abstract Number: 2259

Incidence of Obesity, Diabetes and High Blood Pressure Associated with Arthritis: Analysis of the Canadian Longitudinal National Population Health Survey
Abstract Number: 348

Incidence Rate of Potential Osteonecrosis of the Jaw Among Women with Postmenopausal Osteoporosis Treated with Prolia or Bisphosphonates
Abstract Number: 3135

Incidences and Predictors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal Study
Abstract Number: 1006

Incident Frequent Knee Pain Is Associated with Changes in Semi-Quantitative Imaging Biomarkers of Inflammation
Abstract Number: 1238

Incident Systemic Lupus Erythematosus in Males in a Northern California County Hospital
Abstract Number: 816

Incomplete Tolerance in Anergic B Cells in SLE: T Helper Signals Restore B Cell Receptor Signaling in Autoreactive Anergic B Cells By Upregulating CD45 Phosphatase Activity
Abstract Number: 2064

Increase in IL-31 Serum Level in Recent Onset Spondyloarthritis – Data from the DESIR Cohort
Abstract Number: 243

Increase in Risk of Future Attacks in Patients with Incident Gout: A Population-Based Study over 20 Years
Abstract Number: 1338

Increased Aortic Wall Thickness for the Diagnosis of Aortitis: a Computed Tomography-Based Study
Abstract Number: 1687

Increased Carotid Intima-Media Thickness in Psoriatic Arthritis Patients Compared with Systemic Lupus Erythematosus Patients and Healthy Controls
Abstract Number: 2821

Increased CD4 T Cell GM-CSF Production in Spondyloarthritis
Abstract Number: 536

Increased Circulating CD14brightCD16+ Intermediate Monocytes Are Regulated By TNF-Alpha and IL-6 Axis in Accompany with Disease Activity in Rheumatoid Arthritis Patients
Abstract Number: 1910

Increased Circulating CD204/CD206 Double Positive Monocyte/Macrophages in Systemic Sclerosis Patients with “Early” Capillaroscopic Pattern of Microvascular Damage
Abstract Number: 3056

Increased Circulating Th17 Cells, Serum IL-17 and Serum IL-23 in Takayasu’s Arteritis
Abstract Number: 2535

Increased Direct Healthcare Costs in SLE Pregnancies
Abstract Number: 1848

Increased Expression of Bruton Tyrosine Kinase in Patients with Lupus Nephritis and Its Clinic Significance
Abstract Number: 1981

Increased Extracellular Water Measured By Bioimpedance Analysis in Polymyalgia Rheumatica Patients – Sign of Volume Overload
Abstract Number: 1588

Increased Fracture Risk in Patients with Early Rheumatoid Arthritis: A Prospective General Population-Matched Cohort Study
Abstract Number: 2809

Increased Frequencies of IL-23R Positive T Cells and IL-22 and IL-17 Producing MAIT Cells in the Peripheral Blood of Patients with Ankylosing Spondylitis: Preliminary Results.
Abstract Number: 2715

Increased Frequency of Dysfunctional Hematopoietic Stem and Progenitor Cell Subpopulations in Treatment Naïve Rheumatoid Arthritis Patients
Abstract Number: 3260

Increased Frequency of Malignancies Synchronous to the Onset of Systemic Sclerosis in Anti-RNA Polymerase III Antibodies Positive Patients: A Eustar Multicentre Study
Abstract Number: 2798

Increased Frequency of the PTPN22W* Variant in Primary Sjögren’s Syndrome-Association with Low Type I IFN Scores in Peripheral Blood
Abstract Number: 3003

Increased Heparanase Expression in Keratinocytes Promotes Dermal Fibrosis in Scleroderma
Abstract Number: 1094

Increased IgA Plasmablasts Are Associated with Rheumatoid Arthritis-Related Autoantibodies in the Absence of Inflammatory Arthritis
Abstract Number: 55

Increased Incidence of Tuberculosis Among Systemic Lupus Erythematous Patients – Should Tuberculosis Screening at Diagnosis be the Next Step?
Abstract Number: 1850

Increased Levels of Immunoglobulin Binding Protein 1 Are Associated with Disease Activity Including Renal Damage in Patients with Systemic Lupus Erythematosus
Abstract Number: 3030

Increased Localization of Spleen Tyrosine Kinase (Syk) in Lipid Rafts of in Vitro TCR/CD3-CD28 Activated Lupus T Cells
Abstract Number: 2582

Increased Morbidity and Mortality in Female Versus Male Tumor Necrosis Factor-Transgenic Mice
Abstract Number: 40

Increased Mortality in Indigenous North Americans Persons with Rheumatoid Arthritis Is Partially Explained By Psychiatric and Physical Comorbidity: a Population Based Study
Abstract Number: 2471

Increased Muscle Interferon-Gamma Expression Levels in Juvenile Dermatomyositis
Abstract Number: 1737

Increased Osteoclast Precursors with an Elevated DC-STAMP Expression May Identify Psoriasis Patients at Risk for Psoriatic Arthritis
Abstract Number: 2822

Increased Peripheral Blood CCR6+/IL-23R+ Gamma Delta T Cells Are Associated with High Disease Activity in Patients with Axial Spondyloarthritis
Abstract Number: 3029

Increased Plasticity of Non-Classic Th1 Cells Towards the Th17 Phenotype
Abstract Number: 223

Increased Platelet Reactivity in Gout: A Potential Mechanism for Adverse Cardiovascular Events
Abstract Number: 1511

Increased Prevalence of Anti-Nuclear and Anti-SSA Autoantibodies in African American Rheumatoid Arthritis Patients Versus Matched Caucasian Rheumatoid Arthritis Patients
Abstract Number: 2191

Increased Risk of Acute and Chronic Renal Lesions Associated with Antiphospholipid Antibodies in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
Abstract Number: 2534

Increased Risk of Allergic Conditions in Children Born to Women with SLE
Abstract Number: 1059

Increased Risk of Atrioventricular Block, Atrial Fibrillation and Pacemaker Implantation in Ankylosing Spondylitis, Undifferentiated Spondylarthritis and Psoriatic Arthritis Compared to the General Population
Abstract Number: 2193

Increased Risk of Hemolytic Anemia Associated with Antiphospholipid Antibodies in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
Abstract Number: 2182

Increased Risk of Livedo Reticularis Associated with Antiphospholipid Antibodies in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
Abstract Number: 2192

Increased Risk of Thrombocytopenia Associated with Antiphospholipid Antibodies in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
Abstract Number: 1504

Increased Risk of Thromboembolism Among Patients with VTE Association with Rheumatoid Arthritis
Abstract Number: 3226

Increased Serum Levels of IgG Antibodies Against to Alpha-Enolase Are Associated with Severity of Oral Ulcers in Patients with Behcet’s Disease
Abstract Number: 496

Increased Serum Lipids Under Tocilizumab Is Not Influenced By Methotrexate
Abstract Number: 1924

Increased Stat1 and Stat 1 Phosphorylation in Patients with Systemic Sclerosis (SSc)
Abstract Number: 3102

Increasing Circulating Adiponectin after DMARD Initiation Is Associated with Radiographic Progression in Early Aggressive RA, Regardless of Treatment Strategy
Abstract Number: 1419

Increasing Comorbidity Is Associated with Worsening Physical Function during Intermediate-Term Follow-up of Primary Total Knee Arthroplasty
Abstract Number: 2274

Increasing Moderate-to-Vigorous Activity and Decreasing Sedentary Time Are Associated with 2-Year Weight Loss in Obese Persons with or at Risk for Knee Osteoarthritis
Abstract Number: 189

Indocyanine Green (ICG) -Enhanced Fluorescence Optical Imaging (FOI) in Patients with Active Rheumatoid Arthritis; A Comparative Study with Ultrasound and Association with Biomarkers
Abstract Number: 2975

Induced Sputum Analysis in Systemic Sclerosis Patients
Abstract Number: 2417

Induction and Maintenance of Remission By Etanercept in Enthesitis Related Arthritis JIA-Patients
Abstract Number: 556

Induction-Maintenance in Early RA: A Meta-Analysis of Trials Using MTX Plus Adalimumab As Induction Therapy
Abstract Number: 1294

Infection and Screening Costs Related to Tumor Necrosis Factor-Alpha Inhibitor Use
Abstract Number: 1224

Infection Rate in HIV Patients Who Received TNF-a Inhibitor Therapy for Concomitant Autoimmune Diseases
Abstract Number: 1789

Infections Observed in Rituximab Treated Patients with Refractory Systemic Lupus Erythematosus (SLE): Results from a National Multicentre Register
Abstract Number: 3206

Inflammation on MRI in Sacroiliac-Joints and Spine Is Longitudinally Related to Disease Activity in Male but Not in Female Patients with Axial Spondyloarthritis: 2-Year Data from the DESIR Cohort
Abstract Number: 1302

Inflammation Signs on Magnetic Resonance Imaging in Chronic or Recurrent Gonarthritis Treated with Intra-Articular Infliximab or Corticosteroids
Abstract Number: 2318

Inflammatory Arthritis Patient Perspectives on Strategies to Support Medication Adherence: A Qualitative Study Using a Novel Group Exercise
Abstract Number: 1461

Inflammatory Bowel Disease in Children with Systemic Juvenile Idiopathic Arthritis
Abstract Number: 241

Inflammatory Syndrome in Polyarticular Gout – Description of a Previously Neglected Entity
Abstract Number: 2881

Infliximab in Spondyloarthritis Patients: Utility of Drug Level Monitoring
Abstract Number: 2036

Infliximab Versus Adalimumab in Severe Uveitis: Multicenter Study from the French Uveitis Network
Abstract Number: 1663

Influence of Age and Renal Impairment on Pharmacokinetics of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor
Abstract Number: 2657

Influence of Anxiety and Depression on the Swollen to Tender Joint Count Ratio: In Pursuit of a Phenotype of RA Patients with Somatic Complaints in a U.S. Veteran Population
Abstract Number: 836

Influence of B Cell Depletion By Monoclonal Anti CD20 Antibodies in Systemic Sclerosis: Results of a Randomized Placebo Controlled Trial
Abstract Number: 504

Influence of CDAI Measurement on the Decision of Community Rheumatologists to Initiate or Change Biologic Treatment
Abstract Number: 2091

Influence of Increasing Physical Activity on Longitudinal Changes in Disability Status Among Inactive Older Adults
Abstract Number: 90

Influence of Susceptible HLA-DRB1 Alleles on Clinical Subphenotypes of Systemic Lupus Erythematosus in Koreans
Abstract Number: 7

Influence of TNF on Anti-Inflammatory Tyrosine-Hydroxylase-Positive Synovial Cells in Rheumatoid Arthritis and Osteoarthritis
Abstract Number: 2104

Influence on Treatment Decision Making of Providing Numerical Ranges of Side-Effect Risks
Abstract Number: 2964

Influences of Various Factors on Survival of Patients Treated with Pulmonary Arterial Hypertension-Specific Drugs Combination Therapy in Patients with Connective Tissue Diseases
Abstract Number: 1107

Inhibition of B Cell Activation and Plasma Cell Differentiation By Epratuzumab, a Humanized Monoclonal Antibody Targeting CD22
Abstract Number: 2205

Inhibition of Dickkopf1 Dampens Anti Osteogenic Effect of Fibroblast-like Synoviocytes
Abstract Number: 2154

Inhibition of Gli Ameliorates the Pro-Fibrotic Effects of Transforming Growth Factor-Î² in Systemic Sclerosis
Abstract Number: 2554

Inhibition of IL6 Receptor Improves Arthritis and Atherosclerosis in a Mouse Model of Rheumatoid Arthritis
Abstract Number: 3188

Inhibition of Lymphatic Muscle Contraction By Lymphatic Endothelial iNOS Impairs Lymph Drainage from Arthritic Joints in TNF-Tg Mice and Is Prevented By Herbal Drugs
Abstract Number: 2086

Inhibition of Macrophage Inflammatory Protein 1-Alpha (CCL3) Significantly Reduced Bone Resorption in Vitro and the Development of Erosive Joint Pathology in Collagen-Induced Arthritis
Abstract Number: 2151

Inhibition of Myeloid-Associated Gene Expression in Skin Biopsy Samples of Systemic Sclerosis Patients Treated with Tocilizumab
Abstract Number: 1907

Inhibition of Phosphodiesterase 4 (PDE4) Reduces Dermal Fibrosis By Interfering with the Release of Pro-Fibrotic Cytokines from M2-Macrophages
Abstract Number: 2155

Inhibition of Sphingosine-1-Phosphate Signaling By AB22 As a Novel Strategy in the Treatment of Pulmonary Fibrosis Associated with Scleroderma
Abstract Number: 902

Inhibitor of DNA Binding 1 As a Fibroblast Derived Inflammatory Angiogenic Agonist in Rheumatoid Arthritis
Abstract Number: 3095

Initial Results of a Pilot Juvenile Localized Scleroderma (jLS) Comparative Effectiveness Study
Abstract Number: 1831

Initial Risk Factor Profile and Long-Term Cardiovascular Outcome in Women with Systemic Lupus Erythematosus
Abstract Number: 1502

Initiating Statin Medication and Risk of Fatigue in Rheumatoid Arthritis
Abstract Number: 2107

Initiation of Combination Triple Therapy in Real World Clinical Practice Rarely Replicates the Protocols Used in Randomized Controlled Trials.
Abstract Number: 1564

Initiation of Disease Modifying Therapies and Subsequent Weight Change in Rheumatoid Arthritis
Abstract Number: 1787

Innate Immunity, Arterial Inflammation and Vascular Stiffness in Patients with Systemic Lupus Erythematosus
Abstract Number: 201

Innate Lymphoid Cells Are Present at Normal Human Enthesis Providing a Potential Mechanism for Spondyloarthropathy Pathogenesis
Abstract Number: 1365

Innate Lymphoid Cells. New Players in Systemic Sclerosis Correlate with Extent of Skin and Lung Fibrosis
Abstract Number: 3097

Innovative Approach for the Identification of an Appropriate Dose Regimen of a Targeted Treatment, NI-0501, an Anti-Interferon Gamma (IFNg) Antibody, in Patients with Hemophagocytic Lymphohistiocytosis (HLH)
Abstract Number: 423

Institutional and Regional Variation in Childhood SLE 30-Day Hospital Readmission Rates: A Comparative Effectiveness Research Using the Pediatric Health Information System Database
Abstract Number: 2974

Insulin Resistance Is Associated with the Digital Ulcer in Patients with Systemic Sclerosis
Abstract Number: 1797

Insulin Resistance Is Not Associated with Increased Risk of Subclinical Atheromatosis in Patients with Systemic Lupus Erythematosus from Northern Spain
Abstract Number: 1128

Insulin-Induced Cartilage Degradation in Osteoarthritis Is Associated to Defective Autophagy
Abstract Number: 88

Integrating Evidence for Genetic Association and Natural Selection Helps Detect New Systemic Lupus Erythematosus Risk Loci in African-Americans
Abstract Number: 2386

Integrating Wearable Physical Activity Monitoring Tools into Rehabilitation Practice for Patients with Arthritis: The Healthcare Professional Perspective
Abstract Number: 3129

Integrative Analysis of the Colonic Microbiota in Systemic Sclerosis
Abstract Number: 2106

Intensification to Triple Therapy Non-Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States from 2009 to 2014
Abstract Number: 2913

Intensified Treatment of B Lymphocyte Depletion (ITBLD) without Immunosuppressive Maintenance Treatment As a Rescue Therapy in Refractory Lupus Nephritis (LN): A 4-Year Observation
Abstract Number: 1873

Inter and Intrarater Reliability of the Modified Rodnan Skin Score in Early Diffuse Systemic Sclerosis
Abstract Number: 407

Inter-Observer Variability of the Histological Classification of Lupus Glomerulonephritis in Children
Abstract Number: 3147

Inter-Provider Reliability in Scoring the Physician Global Assessment of Disease Activity Among Patients with Juvenile Idiopathic Arthritis Patients Who Met the ACR Provisional Criteria for Clinical Inactive Disease
Abstract Number: 1962

Inter-Rater Analysis of Ultrasound and Histological Findings in Patients with Suspected Giant Cell Arteritis
Abstract Number: 1321

Inter-Reader Agreement of a Novel Method of Radiographic Scoring of Rheumatoid Arthritis
Abstract Number: 2467

Interaction Between Senescent T Cells and Fibrocyte-like Cells through CD31, TNFα, and IL-17 Create a Tissue Destructive Environment in the Synovium in Juvenile Idiopathic Arthritis
Abstract Number: 3113

Interest of Assessing Anti-Drug Antibodies for the Choice Between a Second Anti-TNF and a Non-TNF-Targeted Biologic in Patients with Inadequate Response to a First Anti-TNF : Results from the Randomized Controlled Trial « Rotation or Change »
Abstract Number: 805

Interferon Activity in Early and Established SLE: Interferon Score Is Lower in Early Disease and Not Seen without Antibodies to Extractable Nuclear Antigens
Abstract Number: 3076

Interferon Gamma (IFNg) Is the Driving Mediator of Secondary Hemophagocytic Lymphohistiocytosis (sHLH) in TLR9-Mediated Pathogenesis in Mice and Is Correlated to Disease Parameters in Children
Abstract Number: 3131

Interferon Regulatory Factor 7 (IRF7): The Possible Link Between Inflammation and Fibrosis in SSc Pathogenesis
Abstract Number: 803

Interferon-Alpha Mediated Lowering of Pentraxin-3 Levels in Systemic Lupus Erythematosus?
Abstract Number: 3096

Interferon-Gamma (IFNg) in Macrophage Activation Syndrome (MAS): CXCL9 Levels As a Biomarker for IFNg Production in MAS
Abstract Number: 1098

Interleukin-1 Reciprocally Regulates Interferon-Gamma Induced B Cell Activating Factor of the Tumor Necrosis Factor Family (BAFF) and Interleukin-6 in Human Synovial Fibroblasts
Abstract Number: 2207

Interleukin-32Î³ Exhibited Protective Effects on Osteoporosis
Abstract Number: 287

Interleukin-35 in Idiopathic Inflammatory Myopathies
Abstract Number: 1925

Interleukin-35 Is Upregulated in Systemic Sclerosis and Its Serum Levels Are Increased in Early Disease
Abstract Number: 1176

Interleukin-37 Prevents New-Onset Joint Inflammation but Does Not Inhibit Existing Experimental Arthritis
Abstract Number: 1189

Internal Medicine Subspecialty Fellows’ Attitudes Towards Teaching and Learning How to Teach: A Needs Assessment
Abstract Number: 1961

Interobserver Agreement on Ultrasonographic and Magnetic Resonance Angiography Findings in Patients with Large Vessel Vasculitis
Abstract Number: 2968

Interrater Reliability of Nailfold Capillaroscopy in Systemic Sclerosis Using Widefield Microscopy
Abstract Number: 1983

Interspinous Bursitis Evaluation By Ultrasound Is Very Useful for Diagnosis of Polymyalgia Rheumatica
Abstract Number: 2375

Interstitial Lung Disease in Patients with Anti-PM-Scl Antibody
Abstract Number: 1025

Interstitial Lung Disease in Sting-Associated Vasculopathy with Onset in Infancy (SAVI): Genotype-Phenotype Correlation
Abstract Number: 897

Intra-Articular Corticosteroids Are Safe and Have No Major Effect on Structural Progression of Synovitic Knee OA: A 2-Year Randomized Controlled Trial of 3-Monthly Triamcinolone Hexacetonide
Abstract Number: 2115

Intra-Operative Synovitis Predicts Worse Pain and Function 2 Years after Total Knee Arthroplasty for Osteoarthritis
Abstract Number: 2895

Intraarticular Sacroiliac Corticosteroid Injections in Ankylosing Spondylitis
Abstract Number: 2712

Intracellular O-Glc-Nac Alterations in Mononuclear Blood Cell of Rheumatoid Arthritis Patients
Abstract Number: 904

Intracerebroventricular Tweak (TNF-like weak inducer of apoptosis) Induces Depressive-like Behavior and Cognitive Dysfunction in Non-Autoimmune Mice
Abstract Number: 887

Intravenous Immunoglobulin As Immunomodulating Agent in ANCA-Associated Vasculitides: A French Nationwide Study of 92 Patients
Abstract Number: 3000

Intrinsic Gene Expression Subset Predicts Improvement in Systemic Sclerosis Patients during Dasatinib (SprycelTM) Therapy
Abstract Number: 271

Investigating an Auto-Inflammatory Component of COPD That Contributes to Progressive Decline in Lung Function Despite Smoking Cessation
Abstract Number: 517

Investigating Psychological Predictors of Biologic Treatment Response in Patients with Severe Active Rheumatoid Arthritis
Abstract Number: 3107

Investigating the Ameliorating Effect of Pregnancy on Rheumatoid Arthritis Using Whole Transcriptome Analysis
Abstract Number: 298

Investigating the Pathogenic Role of ER Stress Pathway Activation in the Idiopathic Inflammatory Myopathies (IIM): Skeletal Muscle Cells As a Source of Cytokines (Myokines)
Abstract Number: 306

Investigating the Pathogenic Role of ER Stress Pathways in the Idiopathic Inflammatory Myopathies (IIM): Interrogating the Role of Micro-RNA 133a As an Important Regulator of ER Stress Activation
Abstract Number: 1362

Investigating the Role of Dendritic Cell Maturation & T Cell Activation within the Inflamed Synovium in Rheumatoid Arthritis
Abstract Number: 715

Investigating the Role of Vitamin D in Patients with SLE
Abstract Number: 24

Investigating the Role of Vitamin D in the Transition to Systemic Lupus Erythematosus in Individuals at Risk for the Disease
Abstract Number: 2296

Investigation of Environmental Associations of Fibromyalgia Pain Using Twitter Content Analysis
Abstract Number: 257

Investigation of the Arterial Stiffness and Associated Factors in Patients with Familial Mediterranean Fever
Abstract Number: 1212

Investigation of Vitamin D Supplement Use, Rheumatoid Arthritis-Related Autoimmunity and Joint Signs Among Those at Increased Risk for the Development of Rheumatoid Arthritis
Abstract Number: 647

Involvement of Peripheral Nervous System in Primary Sjögren Syndrome, a Gessar Analysis
Abstract Number: 2553

Involvement of M2 Macrophages in the Pathogenesis of Arthritis in a Mouse Model
Abstract Number: 932

IRF4-Dependent and IRF4-Independent Pathways Contribute to DC Dysfunction in Lupus
Abstract Number: 3081

IRF5 Deletion Prevents the SLE-like Disease Initiated By Dendritic Cell-Specific Loss of Caspase 8
Abstract Number: 695

Is a Geriatric Rheumatology Sub-Group Worth Distinguishing? Disease Characteristics of a Geriatric Psoriatic Arthritis (Gero PsA) Subgroup Compared with Those of below 45 Years of Age
Abstract Number: 2862

Is Anti-TNF Tapering Possible in Patients with Axial Spondyloarthritis? a Systematic Literature Review
Abstract Number: 704

Is Axial Involvement Underestimated in Patients with Psoriatic Arthritis? Data from the Bepas Cohort
Abstract Number: 2735

Is Disease Duration an Independent Predictor of Treatment Response Among Patients with Rheumatoid Arthritis Initiating Abatacept?
Abstract Number: 698

Is It Possible to Identify Psoriasis Patients Who Will Develop Axial Disease? Real Life Data from Psart (Psoriatic Arthritis Registry of Turkey)
Abstract Number: 2676

Is It Useful to Determine All Rheumatoid Factors Isotypes to Enhance Rheumatoid Arthritis Detection? a Clinical Laboratory Perspective
Abstract Number: 437

Is Mode of Action Important When Switching Biologic Monotherapy in Rheumatoid Arthritis? Drug Adherence Results from the Swedish Ssatg Registry
Abstract Number: 1303

Is MRI More Sensitive Than Conventional Radiographs to Detect Hand Osteoarthritis Progression over 5 Years Follow-up?
Abstract Number: 1316

Is MRI of Use in Identifying Which Undifferentiated Arthritis Patients Will Develop RA?
Abstract Number: 2931

Is Pregnancy a Risk Factor for the Onset of Systemic Lupus Erythematosus (SLE) in Women of the Reproductive Age: A Population Based Case-Control Study?
Abstract Number: 2266

Is Rheumatic Disease Really More Severe in Indigenous Populations? a Systematic Review of Clinical Outcomes in Indigenous Populations of Canada, the United States, Australia and New Zealand
Abstract Number: 702

Is Skin Disease More Important to Patients or Physicians in the Assessment of Disease Activity in Psoriatic Arthritis?
Abstract Number: 701

Is Skin Disease More Important to Women or Men in the Assessment of Disease Activity in Psoriatic Arthritis?
Abstract Number: 2816

Is the Gender Difference in As Linked to IL-23?
Abstract Number: 1881

Is the Presence of Esophageal Dilation a Poor Prognostic Factor in Dilated Interstitial Lung Disease Associated with Systemic Sclerosis?
Abstract Number: 413

Is There a Difference in the Presentation of Diffuse and Limited Subtype of Juvenile Systemic Sclerosis in Childhood? Results from the Juvenile Scleroderma Inception Cohort Www.Juvenile-Scleroderma.Com
Abstract Number: 1793

Is There a Relationship Between Antimalarial Treatment and Elevated Muscle Enzymes in Systemic Lupus Erythematosus
Abstract Number: 1401

Is There Any Difference Between Autoimmune or Hemato-Oncology Etiology of Macrophage Activation Syndrome?
Abstract Number: 1736

Is There Evidence to Support Replacing Conventional AP Pelvis Radiographs with Dedicated Sacroiliac Joint Views for the Diagnosis of Sacroiliitis?
Abstract Number: 2295

Is There Peripheral Large Nerve Involvement in Fibromyalgia? a Systematic EMG / Nerve Conduction Study Evaluation of 55 Consecutive FM Patients
Abstract Number: 3184

Is Treat-to-Target Really Working? a Longitudinal Analysis in Biodam
Abstract Number: 1523

Ischemia Modified Albumin Levels in Rheumatoid Arthritis
Abstract Number: 632

Isolated Atrioventricular Block of Unknown Origin in the Adult and Autoimmunity: Diagnostic and Therapeutic Considerations Exemplified By Three Anti-Ro/SSA-Associated Cases
Abstract Number: 1928

Isolation and Initial Characterization of Dermal Vascular Smooth Muscle Cells in Systemic Sclerosis
Abstract Number: 703

Isotretinoin-Induced Spondilartropathy-Related Symptoms: A Prospective Study
Abstract Number: 269

Items of Yamaguchi Criteria Might be Associated with Disease Severity and Prognosis in Adult-Onset Still’s Disease
Abstract Number: 2145

Ixekizumab Improves Physical Function, Quality of Life, and Work Productivity in Biologic Disease-Modifying Antirheumatic Drug-Naive Patients with Active Psoriatic Arthritis